74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Revvity Inc
Closed
Sector Healthcare
113.63 -0.8
Overview
Share price change
24h
Min
113.28
Max
114.11
Income | 95M |
|---|---|
Sales | 45M 729M |
P/E Sector Avg | 50.004 73.394 |
EPS | 1.42 |
Dividend yield | 0.24 |
Profit margin | 12.976 |
Employees | 11,000 |
EBITDA | -97M 119M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +19.8 upside |
Dividend yield Sector Avg | 0.24% 3.09% |
|---|---|
Next Earnings | 28 Apr 2025 |
Next Dividend date | 9 May 2025 |
Next Ex Dividend date | 18 Apr 2025 |
Market Cap | -1.6B 14B |
|---|---|
Previous open | 114.43 |
Previous close | 113.63 |
News Sentiment
By Acuity
43%
57%
141 / 393 Healthcare
Revvity Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Revvity Inc Forecast
Price Target
By TipRanks
19.8% upside
12 Months Forecast
Average 136.38 USD 19.8%
High 145 USD
Low 120 USD
Based on 13 Wall Street analysts offering 12 month price targets forRevvity Inc - Dist in the last 3 months.
Sentiment
By Acuity
141 / 393 Healthcare
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Revvity Inc
PerkinElmer, Inc. is a provider of products, services and solutions for the diagnostics, life sciences and applied markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides products and services targeted towards the life sciences and applied markets. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the reproductive health, immunodiagnostics and applied genomics markets. The Company provides early detection for genetic disorders from pregnancy to early childhood, and infectious disease testing for the diagnostics market. It offers its products under various brand names, including AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BoBs, chemagic, Chitas, Datalytix, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROline, EUROPattern, FragilEase, Genoglyphix, GSP, and Haoyuan.
